TRANSMEDICS GROUP INC (1TMDX.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1TMDX - US89377M1099 - Common Stock
1TMDX.MI Key Statistics, Chart & Performance
The current stock price of 1TMDX.MI is 113.7 EUR.
1TMDX.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.39 | 114.62B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.68 | 114.29B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.93 | 48.35B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.39 | 23.36B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.37 | 23.33B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.67 | 23.11B | ||
| BIM.PA | BIOMERIEUX | 28.2 | 12.88B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 156.01 | 4.69B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.14 | 4.00B | ||
| DIA.MI | DIASORIN SPA | 18.62 | 3.45B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.87 | 1.32B | ||
| DRW8.DE | DRAEGERWERK AG | 9.92 | 1.20B |
Related stock screener links
About 1TMDX.MI
Company Profile
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 728 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Company Info
TRANSMEDICS GROUP INC
200 Minuteman Road
Andover MASSACHUSETTS US
Employees: 728
Phone: 19785520900
TRANSMEDICS GROUP INC / 1TMDX.MI FAQ
Can you describe the business of TRANSMEDICS GROUP INC?
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 728 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
What is the current price of 1TMDX stock?
The current stock price of 1TMDX.MI is 113.7 EUR. The price increased by 9.38% in the last trading session.
What is the dividend status of TRANSMEDICS GROUP INC?
1TMDX.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1TMDX stock?
1TMDX.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of 1TMDX stock?
TRANSMEDICS GROUP INC (1TMDX.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Who owns TRANSMEDICS GROUP INC?
You can find the ownership structure of TRANSMEDICS GROUP INC (1TMDX.MI) on the Ownership tab.
1TMDX.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1TMDX.MI.
1TMDX.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1TMDX.MI. Both the profitability and the financial health of 1TMDX.MI get a neutral evaluation. Nothing too spectacular is happening here.
1TMDX.MI Financial Highlights
Over the last trailing twelve months 1TMDX.MI reported a non-GAAP Earnings per Share(EPS) of 2.13. The EPS increased by 162.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.49% | ||
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| Debt/Equity | 1.61 |
1TMDX.MI Forecast & Estimates
18 analysts have analysed 1TMDX.MI and the average price target is 130.49 EUR. This implies a price increase of 14.77% is expected in the next year compared to the current price of 113.7.
For the next year, analysts expect an EPS growth of 138.61% and a revenue growth 39.65% for 1TMDX.MI